One case involving a MET gene fusion, specifically PTPRZ(1)::MET(2), was identified (female patient, age 74), as well as one case of FGFR3:TACC3 fusion (the most common FGFR fusion reported in NSCLC) co-occurring with the EGFR L858R mutation (female patient, age 72) [27]. Here, MET is linked to non-small cell lung carcinoma.